Recurrent hematological toxicity after second-line treatment in patients with glioblastoma: indication of a potential predisposition
Year: 2025
Type: article
Language: en
Topic: Glioma Diagnosis and Treatment
Authors and affiliations:
raw_author_name: Leon van Hout
raw_affiliation_strings: Cancer Center Amsterdam, Treatment and Quality of Life , Amsterdam, 1081HV,
Department of Neurology, Amsterdam UMC , De Boelelaan 1117 , Amsterdam, 1081HV,
Department of Neurosurgery, Amsterdam UMC , Amsterdam, 1081HV,
Department of Neurosurgery, Amsterdam UMC, De Boelelaan 1117, Amsterdam, The Netherlands
Cancer Center Amsterdam, Treatment and Quality of Life, De Boelelaan 1117, Amsterdam, The Netherlands
raw_author_name: Femke E L van den Elzen
raw_affiliation_strings: Department of Neurology, Amsterdam UMC , De Boelelaan 1117 , Amsterdam, 1081HV,
Department of Neurology, Amsterdam UMC, De Boelelaan 1117, Amsterdam, The Netherlands
raw_author_name: Zoë de Jong
raw_affiliation_strings: Department of Neurology, Amsterdam UMC , De Boelelaan 1117 , Amsterdam, 1081HV,
Department of Neurology, Amsterdam UMC, De Boelelaan 1117, Amsterdam, The Netherlands
raw_author_name: Nienke Grun
raw_affiliation_strings: Department of Neurology, Amsterdam UMC , De Boelelaan 1117 , Amsterdam, 1081HV,
Department of Neurology, Amsterdam UMC, De Boelelaan 1117, Amsterdam, The Netherlands
raw_author_name: Martinus P G Broen
raw_affiliation_strings: Department of Neurology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre , Maastricht, 6229ER,
Department of Neurology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands
raw_author_name: Imke Bartelink
raw_affiliation_strings: Cancer Center Amsterdam, Imaging and Biomarkers , Amsterdam, 1081HV,
Department of Clinical Pharmacy & Pharmacology, Amsterdam UMC , Amsterdam, 1081HV,
Department of Clinical Pharmacy & Pharmacology, Amsterdam UMC, de Boelelaan 1117, The Netherlands
Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands
raw_author_name: Anna M E Bruynzeel
raw_affiliation_strings: Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam UMC , Amsterdam, 1081HV,
Department of Radiation Oncology, Amsterdam UMC, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands
raw_author_name: Frank J Lagerwaard
raw_affiliation_strings: Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam UMC , Amsterdam, 1081HV,
Department of Radiation Oncology, Amsterdam UMC, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands
raw_author_name: Jan Buter
raw_affiliation_strings: Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC , Amsterdam, 1081HV,
Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands
raw_author_name: William Peter Vandertop
raw_affiliation_strings: Cancer Center Amsterdam, Treatment and Quality of Life , Amsterdam, 1081HV,
Department of Neurosurgery, Amsterdam UMC , Amsterdam, 1081HV,
Cancer Center Amsterdam, Treatment and Quality of Life, De Boelelaan 1117, Amsterdam, The Netherlands
Department of Neurosurgery, Amsterdam UMC, De Boelelaan 1117, Amsterdam, The Netherlands
raw_author_name: Bart A Westerman
raw_affiliation_strings: Department of Human Genetics, Cancer Center Amsterdam, Amsterdam UMC , Amsterdam, 1081HV,
Department of Human Genetics, Amsterdam UMC, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands
raw_author_name: Birgit I Lissenberg—Witte
raw_affiliation_strings: Department of Epidemiology and Data Science, Amsterdam UMC, Vrije Universiteit Amsterdam , Amsterdam, 1081HV,
Department of Epidemiology and Data Science, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands
raw_author_name: Mathilde C M Kouwenhoven
raw_affiliation_strings: Cancer Center Amsterdam, Imaging and Biomarkers , Amsterdam, 1081HV,
Cancer Center Amsterdam, Treatment and Quality of Life , Amsterdam, 1081HV,
Department of Neurology, Amsterdam UMC , De Boelelaan 1117 , Amsterdam, 1081HV,
Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands
Cancer Center Amsterdam, Treatment and Quality of Life, De Boelelaan 1117, Amsterdam, The Netherlands
Department of Neurology, Amsterdam UMC, De Boelelaan 1117, Amsterdam, The Netherlands